A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Traumatic Brain Injury (TBI)

Investigator(s):
Leonid Groysman, M.D.
Organization: 
UCI
NCT Number: 
Disease Name: 
Traumatic Brain Injury
Disease Category: 
Trial Phases: 
Phase 2
Trial Status: 
Active, Not Recruiting
Trial Contact: 

Active trials at UCI: http://clinic.stemcell.uci.edu/search-clinical-trials.asp

Contact for all open studies at UCI:
(949) 824-3990
stemcell@uci.edu